Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia

Renal Failure

Volumn 35, Issue 8, 2013, Pages 1124-1129

  Duan, Shao Bin ^a   Yang, Shi Kun ^a   Zhou, Qiao Yan ^a   Pan, Peng ^a   Zhang, Hui ^a   Liu, Fang ^a   Xu, Xiang Qing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute kidney injury; Contrast media; Mitochondria targeted peptides; NADPH oxidase; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CONTRAST MEDIUM; EOSIN; HEMATOXYLIN; MALONALDEHYDE; MITOCHONDRIAL PROTEIN; MTP131 PROTEIN; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM CHLORIDE; SPI20 PROTEIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHEMICAL PARAMETERS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; KIDNEY INJURY; KIDNEY PARENCHYMA; MITOCHONDRION; NONHUMAN; PERITONEAL CAVITY; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; SPRAGUE DAWLEY RAT; URINALYSIS; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; CONTRAST MEDIA; DIATRIZOATE; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; MALE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84881587276     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.815107     Document Type: Article

References (25)

1. Itoh Y, Yano T, Sendo T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci. 2005; 97: 473-488.
2. Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J. 2012; 33: 2007-2015.
3. Bylund J, Brown KL, Movitz C, Dahlgren C, Karlsson A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic Biol Med. 2010; 49: 1834-1845.
4. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87: 245-313.
5. Murphy MP, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev. 2000; 41: 235-250.
6. Rocha M, Hernandez-Mijares A, Garcia-Malpartida K, Banuls C, Bellod L, Victor VM. Mitochondria-targeted antioxidant peptides. Curr Pharm Des. 2010; 16: 3124-3131.
7. Kloner RA, Hale SL, Dai W, et al. Reduction of ischemia/ reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide. J Am Heart Assoc. 2012; 1: e001644-e001657.
8. Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2008; 10: 601-619.
9. Yang D, Lin S, Wei L, Shang W. Effects of short- and long-term hypercholesterolemia on contrast-induced acute kidney injury. Am J Nephrol. 2012; 35: 80-89.
10. Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney Int. 1998; 53: 1736-1742.
11. Yang DW, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J (Engl). 2004; 117: 542-546.
12. Duan SB, Liu GL, Chen GC, Wang P, Pan P, Xu XQ. Aged rats are susceptible to nephrotoxicity induced by iodinated contrast media. Ren Fail. 2013; 35: 150-154.
13. Stulak JM, Lerman A, Caccitolo JA, et al. Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia. Atherosclerosis. 2001; 154: 195-201.
14. Kaplan R, Aynedjian HS, Schlondorff D, Bank N. Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol. J Clin Invest. 1990; 86: 1707-1714.
15. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis. 2004; 57: S28-S29.
16. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011; 21: 2527-2541.
17. Duan SB, Liu FY, Luo JA, et al. Nephrotoxicity of high- and lowosmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol. 2000; 41: 503-507.
18. Duan SB, Wang YH, Liu FY, et al. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Acta Radiol. 2009; 50: 754-759.
19. Quintavalle C, Brenca M, De Micco F, et al. In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2011; 2: e155-e162.
20. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant. 2004; 19: 1803-1807.
21. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013; 17: 204-218.
22. Chen M, Liu B, Gao Q, Zhuo Y, Ge J. Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011; 52: 7027-7037.
23. Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 2004; 279: 34682-34690.
24. Szeto HH, Liu S, Soong Y, et al. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol. 2011; 22: 1041-1052.
25. Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, Felsen D. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2008; 295: F1545-F1553.